[HTML][HTML] A phase 3 trial of bevacizumab in ovarian cancer

TJ Perren, AM Swart, J Pfisterer… - … England Journal of …, 2011 - Mass Medical Soc
Background Angiogenesis plays a role in the biology of ovarian cancer. We examined the
effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women …

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

SE Bojesen, KA Pooley, SE Johnatty, J Beesley… - Nature …, 2013 - nature.com
TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of
multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed∼ 480 …

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

L Zhang, S Volinia, T Bonome… - Proceedings of the …, 2008 - National Acad Sciences
MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs that function as
negative gene regulators. miRNA deregulation is involved in the initiation and progression …

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

N Yang, S Kaur, S Volinia, J Greshock, H Lassus… - Cancer research, 2008 - AACR
Abstract MicroRNAs (miRNA) are approximately 22-nucleotide noncoding RNAs that
negatively regulate protein-coding gene expression in a sequence-specific manner via …

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan… - Nature …, 2013 - nature.com
Genome-wide association studies (GWAS) have identified four susceptibility loci for
epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome …

Common variants at 19p13 are associated with susceptibility to ovarian cancer

KL Bolton, J Tyrer, H Song, SJ Ramus, M Notaridou… - Nature …, 2010 - nature.com
Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological
malignancy in the developed world, accounting for 4% of the deaths from cancer in women …

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

JI Kiiski, LM Pelttari, S Khan… - Proceedings of the …, 2014 - National Acad Sciences
Inherited predisposition to breast cancer is known to be caused by loss-of-function mutations
in BRCA1, BRCA2, PALB2, CHEK2, and other genes involved in DNA repair. However, most …

Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome

L Renkonen‐Sinisalo, R Bützow… - … journal of cancer, 2007 - Wiley Online Library
The estimated lifetime risk for endometrial carcinoma (EC) in hereditary nonpolyposis
colorectal cancer syndrome (HNPCC) is 32–60%, thus supporting surveillance. The survival …

[HTML][HTML] Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

H Shen, BL Fridley, H Song, K Lawrenson… - Nature …, 2013 - nature.com
HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic
silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this …

Updating on primary fallopian tube carcinoma

A Riska, A Leminen - Acta Obstetricia et Gynecologica …, 2007 - Taylor & Francis
Primary fallopian tube carcinoma (PFTC) is rare, constituting about 1% of female genital tract
malignancies, and little is known about its etiological, protective, risk or prognostic factors …